TSX/NYSE/PSE: MFC SEHK:945
WATERLOO, ON, Aug. 21, 2014 /CNW/ - Manulife has entered into an
exclusive partnership with one of Canada's leading health care
providers, Bayshore HealthCare Ltd, to deliver a Specialty Drug Care
program. The program features drug case management services and a
preferred provider network.
Manulife's Specialty Drug Care program is designed to enhance patient
care for individuals managing complex medical conditions treated with
high cost specialty drugs. The program's case management services will
include education, health coaching, side-effect management, medication
adherence and regular follow-ups.
"This partnership is unique within the Canadian marketplace as it
increases the level of care being provided to patients taking specialty
drugs and with Bayshore's network of 10,000 healthcare professionals,
we are delivering a national solution that is supported by community
based resources," said Lisa Callaghan, Assistant Vice President Product
Group Benefits, Manulife. "In addition, the program helps contain costs
for our plan sponsors and members. With specialty drug costs increasing
by 10 per cent year-over-year*, managing this trend is becoming
The pharmacy network will provide preferred pricing and will leverage
Bayshore's Specialty Rx Pharmacy network to meet the logistical demands
required to get these high cost medications safely in the hands of the
patient at their home, infusion clinic, doctor's office or preferred
The Specialty Drug Care program features:
Case management and care coordination
Access to financial and community resources
National reach with community based support
Options for medication dispensing and delivery
Improved health outcomes
"Bayshore is very excited to partner with Manulife to provide tailored
specialty drug case management for Manulife's plan members and their
families. Our experienced nursing network, coupled with our expertise
in managing pharmaceutical therapies and disease states, will lead to
improving health outcomes through this new program," said Stuart J.
Cottrelle, President of Bayshore HealthCare.
Specialty Drug Care is scheduled to be introduced later this year.
* Express Scripts Canada Drug Trend Report 2013.
Manulife is a leading Canada-based financial services group with
principal operations in Asia, Canada and the United States. Clients
look to Manulife for strong, reliable, trustworthy and forward-thinking
solutions for their most significant financial decisions. Our
international network of employees, agents and distribution partners
offers financial protection and wealth management products and services
to millions of clients. We also provide asset management services to
institutional customers. Funds under management by Manulife and its
subsidiaries were approximately C$637 billion (US$597 billion) as at
June 30, 2014. Our group of companies operates as Manulife in Canada
and Asia and primarily as John Hancock in the United States. Manulife
Financial Corporation trades as 'MFC' on the TSX, NYSE and PSE, and
under '945' on the SEHK. Manulife can be found on the Internet at manulife.com.
Bayshore HealthCare Ltd. a Canadian-owned company, is one of the
country's leading providers of home and community health care services.
They provide services to government care programs, insurance companies,
workers' compensation boards, health care organizations, the corporate
sector and the public. The Bayshore brand extends across four business
divisions: Bayshore Home Health (medical and non-medical home care and
staffing services), Bayshore Specialty Rx (specialty pharmacy, infusion
and pharmaceutical patient support services), Bayshore Therapy & Rehab
(physiotherapy and rehabilitation services) and Bayshore Dialysis
(dialysis centers). The company's goal is to enhance the quality of
life, well-being, dignity and independence of Canadians of all ages.
Bayshore HealthCare has been a recipient of Canada's Best Managed
Companies award since 2006. For more information, call 1-844-218-5101
or visit www.bayshore.ca.
SOURCE: Manulife Financial Corporation
For further information:
Director Media Relations, Manulife